The current financial score of Metagenomi Inc is 7.12. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached -257.00K, representing a year-over-year decrease of 103.02%, while its net profit experienced a year-over-year decrease of 38.05%.
The current valuation score of Metagenomi Inc is 8.78. Its current P/E ratio is -0.49, which is -2.66% below the recent high of -0.48 and -1268.39% above the recent low of -6.74.
The current earnings forecast score of Metagenomi Inc is 8.00. The average price target is 7.00, with a high of 9.00 and a low of 5.00.
The current price momentum score of Metagenomi Inc is 3.47. Currently, the stock price is trading between the resistance level at 1.22 and the support level at 1.05, making it suitable for range-bound swing trading.
The current institutional shareholding score of Metagenomi Inc is 3.00. The latest institutional shareholding proportion is 23.43%, representing a quarter-over-quarter increase of 31.16%. The largest institutional shareholder is James Simons, holding a total of 742.40K shares, representing 0.00% of shares outstanding, with 493.66% increase in holdings.
The current risk assessment score of Metagenomi Inc is 3.96. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.